Youssef Almoatazbellah, Hollister Scott J, Dalton Paul D
Department for Functional Materials in Medicine and Dentistry and Bavarian Polymer Institute, University of Würzburg, Pleicherwall 2, D-97070 Würzburg, Germany.
Biofabrication. 2017 Feb 28;9(1):012002. doi: 10.1088/1758-5090/aa5766.
Melt processing is routinely used to fabricate medical polymeric devices/implants for clinical reconstruction and can be incorporated into quality systems procedures for medical device manufacture. As additive manufacturing (AM) becomes increasingly used for biomaterials and biofabrication, the translation of new, customizable, medical devices to the clinic becomes paramount. Melt processing is therefore a distinguishable group within AM that provides an avenue to manufacture scaffolds/implants with a clinical end-point. Three key melt processing AM technologies are highlighted in this review: melt micro-extrusion, selective laser sintering and melt electrospinning writing. The in vivo (including clinical) outcomes of medical devices and scaffolds made with these processes are reviewed. Together, they encompass the melt AM of scaffold architectures with feature sizes and resolutions ranging from 800 nm up to 700 μm.
熔融加工通常用于制造用于临床重建的医用聚合物装置/植入物,并且可以纳入医疗器械制造的质量体系程序中。随着增材制造(AM)越来越多地用于生物材料和生物制造,将新型、可定制的医疗器械转化为临床应用变得至关重要。因此,熔融加工是增材制造中一个独特的类别,它为制造具有临床终点的支架/植入物提供了一条途径。本综述重点介绍了三种关键的熔融加工增材制造技术:熔融微挤出、选择性激光烧结和熔融静电纺丝书写。本文回顾了用这些工艺制造的医疗器械和支架的体内(包括临床)结果。它们共同涵盖了特征尺寸和分辨率从800纳米到700微米不等的支架结构的熔融增材制造。